Rabia Johnson Selected Research

Metabolic Syndrome (Dysmetabolic Syndrome X)

12/2020	N-Acetyl Cysteine Targets Hepatic Lipid Accumulation to Curb Oxidative Stress and Inflammation in NAFLD: A Comprehensive Analysis of the Literature.
11/2020	The effect of adiponectin in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) and the potential role of polyphenols in the modulation of adiponectin signaling.
5/2020	Coenzyme Q10 Supplementation Improves Adipokine Levels and Alleviates Inflammation and Lipid Peroxidation in Conditions of Metabolic Syndrome: A Meta-Analysis of Randomized Controlled Trials.
1/2020	In Utero One-Carbon Metabolism Interplay and Metabolic Syndrome in Cardiovascular Disease Risk Reduction.
7/2018	Aspalathin from Rooibos (Aspalathus linearis): A Bioactive C-glucosyl Dihydrochalcone with Potential to Target the Metabolic Syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rabia Johnson Research Topics

Disease

13	Insulin Resistance 01/2022 - 11/2015
9	Type 2 Diabetes Mellitus (MODY) 10/2022 - 01/2018
9	Hyperglycemia 05/2021 - 11/2016
7	Hypertension (High Blood Pressure) 01/2024 - 01/2019
7	Inflammation (Inflammations) 01/2024 - 01/2017
6	Cardiotoxicity 10/2023 - 09/2017
6	Obesity 01/2022 - 01/2014
6	Metabolic Diseases (Metabolic Disease) 12/2021 - 01/2019
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2020 - 07/2018
4	Necrosis 10/2023 - 01/2018
4	Body Weight (Weight, Body) 01/2022 - 08/2017
4	Neoplasms (Cancer) 01/2022 - 09/2017
3	Non-alcoholic Fatty Liver Disease 01/2024 - 11/2020
3	Mitochondrial Diseases (Mitochondrial Disease) 12/2021 - 01/2019
2	COVID-19 03/2023 - 11/2021
2	Cardiovascular Diseases (Cardiovascular Disease) 10/2022 - 01/2020
2	Diabetic Cardiomyopathies 05/2021 - 01/2020
2	Fibrosis (Cirrhosis) 08/2020 - 01/2020
1	Cardiomyopathies (Cardiomyopathy) 10/2023
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2022
1	Ischemia 01/2022
1	Prediabetic State (Prediabetes) 01/2022
1	Reperfusion Injury 01/2022
1	Hypertrophy 12/2021
1	Breast Neoplasms (Breast Cancer) 12/2021
1	Heart Failure 11/2021
1	Hyperlipidemias (Hyperlipidemia) 10/2020

Drug/Important Bio-Agent (IBA)

12	aspalathinIBA 01/2024 - 11/2015
7	Insulin (Novolin)FDA Link 01/2024 - 01/2019
7	AntioxidantsIBA 10/2022 - 01/2018
7	Metformin (Glucophage)FDA LinkGeneric 10/2022 - 11/2016
7	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 11/2016
6	FlavonoidsIBA 10/2023 - 01/2014
5	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2023 - 09/2017
5	Biomarkers (Surrogate Marker)IBA 06/2020 - 01/2018
4	LipidsIBA 01/2024 - 02/2019
4	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2017
3	Therapeutic UsesIBA 01/2024 - 12/2020
3	Phosphotransferases (Kinase)IBA 01/2022 - 01/2019
3	LeptinIBA 12/2021 - 01/2019
3	CytokinesIBA 11/2021 - 11/2020
3	PolyphenolsIBA 11/2020 - 01/2014
3	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2020 - 01/2018
3	PalmitatesIBA 02/2019 - 11/2015
3	dihydrochalconeIBA 07/2018 - 01/2017
2	Caspase 3 (Caspase-3)IBA 01/2024 - 10/2023
2	Dacarbazine (DIC)FDA LinkGeneric 10/2023 - 01/2022
2	WastewaterIBA 03/2023 - 11/2021
2	Antihypertensive Agents (Antihypertensives)IBA 01/2023 - 01/2021
2	SugarsIBA 01/2022 - 01/2019
2	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 01/2022 - 01/2022
2	Triglycerides (Triacylglycerol)IBA 01/2022 - 12/2021
2	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 12/2021 - 01/2018
2	Hypoglycemic Agents (Hypoglycemics)IBA 11/2021 - 01/2018
2	ChemokinesIBA 11/2021 - 01/2021
2	Cysteine (L-Cysteine)FDA Link 12/2020 - 01/2019
2	AdipokinesIBA 11/2020 - 05/2020
2	AdiponectinIBA 11/2020 - 05/2020
2	ubiquinone 9IBA 10/2020 - 01/2019
2	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 08/2020 - 01/2020
2	Protein Kinases (Protein Kinase)IBA 02/2019 - 01/2019
2	Blood Glucose (Blood Sugar)IBA 01/2019 - 01/2018
1	Pioglitazone (Actos)FDA Link 01/2024
1	AngiotensinogenIBA 01/2024
1	Vitamin E FDA LinkGeneric 01/2024
1	7-hydroxyflavanoneIBA 10/2023
1	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 10/2022
1	Malondialdehyde (Propanedial)IBA 10/2022
1	p38 Mitogen-Activated Protein KinasesIBA 01/2022
1	Adenosine Monophosphate (AMP)IBA 01/2022
1	AnthracyclinesIBA 01/2022
1	Protein Isoforms (Isoforms)IBA 01/2022
1	Glycogen Synthase Kinase 3IBA 01/2022
1	Mitogen-Activated Protein Kinase 3IBA 01/2022
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2022
1	Adenosine Triphosphate (ATP)IBA 12/2021
1	SolventsIBA 12/2021
1	ErbB Receptors (EGF Receptor)IBA 12/2021
1	E2F Transcription FactorsIBA 12/2021
1	DNA (Deoxyribonucleic Acid)IBA 12/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 12/2021
1	Enalapril FDA LinkGeneric 11/2021
1	RNA (Ribonucleic Acid)IBA 11/2021
1	Viral RNAIBA 11/2021
1	LigandsIBA 11/2021
1	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2021
1	LDL Lipoproteins (beta Lipoproteins)IBA 11/2021
1	TriterpenesIBA 05/2021
1	LipopolysaccharidesIBA 01/2021
1	Immunoglobulin A (IgA)IBA 01/2021
1	DiureticsIBA 01/2021
1	Protective AgentsIBA 12/2020
1	InterleukinsIBA 12/2020
1	ElastinIBA 08/2020
1	CollagenIBA 08/2020
1	coenzyme Q10 (CoQ10)IBA 05/2020
1	Collagen Type I (Type I Collagen)IBA 01/2020

Therapy/Procedure

7	Therapeutics 01/2024 - 01/2017
1	Glycemic Control 10/2022
1	Complementary Therapies (Alternative Medicine) 01/2022